LMAT - LeMaitre Vascular, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
Burlington,
United States
Type: Equity
LMAT price evolution
LMAT
| (in millions $) | 1 May 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $24.27 | $18.05 | $19.49 | |
| Short term investments | $80.81 | $78.97 | $70.69 | |
| Net receivables | $30.24 | $25.06 | $23.88 | $26.41 |
| Inventory | $60.58 | $58.08 | $56.19 | $53.83 |
| Total current assets | $202.96 | $194.6 | $182.18 | $174.49 |
| Long term investments | ||||
| Property, plant & equipment | $39.97 | $39.78 | $37.21 | $37.02 |
| Goodwill & intangible assets | $107.66 | $109.14 | $109.94 | |
| Total noncurrent assets | $152.18 | $151.83 | $151.98 | |
| Total investments | $80.81 | $78.97 | $70.69 | |
| Total assets | $353.96 | $346.78 | $334.01 | $326.47 |
| Current liabilities | ||||
| Accounts payable | $3.09 | $3.73 | $4.37 | $3.52 |
| Deferred revenue | ||||
| Short long term debt | $2.47 | $2.75 | $2.36 | |
| Total current liabilities | $26.81 | $29.88 | $29.03 | $25.86 |
| Long term debt | $16.62 | $14.13 | $14.45 | |
| Total noncurrent liabilities | $19 | $16.35 | $16.79 | |
| Total debt | $19.09 | $16.88 | $16.81 | |
| Total liabilities | $45.45 | $48.88 | $45.38 | $42.64 |
| Shareholders' equity | ||||
| Retained earnings | $121.73 | $115.43 | $110.08 | $105.7 |
| Other shareholder equity | -$5.56 | -$4.63 | -$6.71 | -$5.82 |
| Total shareholder equity | $297.9 | $288.64 | $283.83 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $24.27 | $19.13 | $13.86 | $26.76 |
| Short term investments | $80.81 | $63.56 | $56.1 | $0.21 |
| Net receivables | $25.06 | $22.04 | $19.63 | $19.55 |
| Inventory | $58.08 | $50.27 | $46.1 | $45.12 |
| Total current assets | $194.6 | $161.73 | $139.88 | $94.26 |
| Long term investments | ||||
| Property, plant & equipment | $39.78 | $33.53 | $32.13 | $31.1 |
| Goodwill & intangible assets | $107.66 | $112.47 | $118.66 | $124.85 |
| Total noncurrent assets | $152.18 | $148.74 | $152.92 | $158.55 |
| Total investments | $80.81 | $63.56 | $56.1 | $0.21 |
| Total assets | $346.78 | $310.48 | $292.8 | $252.81 |
| Current liabilities | ||||
| Accounts payable | $3.73 | $2.9 | $2.34 | $2.39 |
| Deferred revenue | ||||
| Short long term debt | $2.47 | $1.89 | $1.87 | $4.45 |
| Total current liabilities | $29.88 | $25.33 | $21.81 | $25.14 |
| Long term debt | $16.62 | $14.71 | $14.07 | $50.32 |
| Total noncurrent liabilities | $19 | $16.95 | $16.84 | $55.09 |
| Total debt | $19.09 | $16.6 | $15.94 | $54.78 |
| Total liabilities | $48.88 | $42.27 | $38.65 | $80.24 |
| Shareholders' equity | ||||
| Retained earnings | $115.43 | $97.77 | $88.13 | $70.55 |
| Other shareholder equity | -$4.63 | -$6.03 | -$3.44 | -$1.52 |
| Total shareholder equity | $297.9 | $268.2 | $254.15 | $172.57 |
| (in millions $) | 1 May 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $53.48 | $48.88 | $47.41 | $50.12 |
| Cost of revenue | $15.62 | $16.6 | ||
| Gross Profit | $36.66 | $33.27 | $30.82 | $32.09 |
| Operating activities | ||||
| Research & development | $4.35 | $4.22 | ||
| Selling, general & administrative | $18.71 | $17.41 | ||
| Total operating expenses | $24.79 | $23.06 | $21.64 | $22.45 |
| Operating income | $10.21 | $9.18 | ||
| Income from continuing operations | ||||
| EBIT | $11.31 | $9.83 | ||
| Income tax expense | $2.91 | $2.85 | $2.32 | $2.22 |
| Interest expense | $0.92 | $0.87 | ||
| Net income | ||||
| Net income | $9.89 | $8.46 | $7.5 | $8.1 |
| Income (for common shares) | $8.46 | $7.5 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $193.48 | $161.65 | $154.42 | $129.37 |
| Cost of revenue | $66.44 | $56.76 | $53.04 | $44.75 |
| Gross Profit | $127.05 | $104.9 | $101.38 | $84.62 |
| Operating activities | ||||
| Research & development | $16.97 | $13.29 | $11.8 | $10.1 |
| Selling, general & administrative | $72.89 | $61.67 | $53.16 | $46.2 |
| Total operating expenses | $90.34 | $78.07 | $64.96 | $55.83 |
| Operating income | $36.71 | $26.83 | $36.42 | $28.79 |
| Income from continuing operations | ||||
| EBIT | $39.48 | $27.49 | $36.51 | $28.67 |
| Income tax expense | $9.37 | $6.85 | $7.38 | $6.14 |
| Interest expense | $2.22 | $1.31 | ||
| Net income | ||||
| Net income | $30.11 | $20.64 | $26.91 | $21.22 |
| Income (for common shares) | $30.11 | $20.64 | $26.91 | $21.22 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $8.46 | $7.5 | $8.1 | $6.04 |
| Operating activities | ||||
| Depreciation | $2.44 | $2.4 | $2.33 | $2.35 |
| Business acquisitions & disposals | -$0.47 | -$0.16 | -$0.27 | |
| Stock-based compensation | $1.4 | $1.31 | $1.31 | $1.29 |
| Total cash flows from operations | $10.75 | $11.82 | $11.9 | $2.28 |
| Investing activities | ||||
| Capital expenditures | -$1.28 | -$1.05 | -$2.8 | -$2.13 |
| Investments | -$0.98 | -$8.33 | -$6.67 | -$0.56 |
| Total cash flows from investing | -$2.26 | -$9.85 | -$9.64 | -$2.96 |
| Financing activities | ||||
| Dividends paid | -$3.12 | -$3.12 | -$3.12 | -$3.1 |
| Sale and purchase of stock | $0.43 | -$0.01 | $3.62 | $1.27 |
| Net borrowings | ||||
| Total cash flows from financing | -$2.69 | -$3.12 | $0.5 | -$1.82 |
| Effect of exchange rate | $0.42 | -$0.29 | $0.04 | $0.05 |
| Change in cash and equivalents | $6.22 | -$1.44 | $2.81 | -$2.46 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $30.11 | $20.64 | $26.91 | $21.22 |
| Operating activities | ||||
| Depreciation | $9.52 | $9.43 | $11.07 | $8.39 |
| Business acquisitions & disposals | -$0.9 | -$72.63 | ||
| Stock-based compensation | $5.32 | $4.17 | $3.48 | $3.02 |
| Total cash flows from operations | $36.75 | $25.38 | $35.1 | $34.8 |
| Investing activities | ||||
| Capital expenditures | -$7.26 | -$2.37 | -$4.88 | -$0.96 |
| Investments | -$16.55 | -$8 | -$56.19 | $20.7 |
| Total cash flows from investing | -$24.71 | -$10.37 | -$61.08 | -$52.89 |
| Financing activities | ||||
| Dividends paid | -$12.45 | -$10.99 | -$9.34 | -$7.7 |
| Sale and purchase of stock | $5.32 | $2.82 | $62.44 | $5.4 |
| Net borrowings | -$39 | $39 | ||
| Total cash flows from financing | -$7.13 | -$9.23 | $13.7 | $32.16 |
| Effect of exchange rate | $0.23 | -$0.49 | -$0.64 | $0.91 |
| Change in cash and equivalents | $5.13 | $5.28 | -$12.91 | $14.98 |
News
Fundamentals
| Market cap | $1.70B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 22.34M |
| Revenue | $199.89M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $33.95M |
| Revenue Q/Q | 13.60% |
| Revenue Y/Y | 18.16% |
| P/E ratio | 50.09 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 8.51 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.52 |
|---|---|
| ROA | 9.98% |
| ROE | N/A |
| Debt/Equity | 0.16 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 7.57 |
| Quick ratio | 5.31 |